- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06788496
Art-based Beauty Appreciation Intervention (ABBA-vention)
August 15, 2025 updated by: Radboud University Medical Center
RCT Pilot Study: Art-based Beauty Appreciation Intervention
This study is a randomized controlled trial with an active control condition evaluating the impact of an art-based beauty appreciation (ABBA) intervention on trait appreciation of beauty as a primary outcome and well-being and psychological distress as secondary outcomes.
The central hypothesis is that the primary and secondary outcomes will increase more in the intervention than in the control condition.
Study Overview
Status
Completed
Conditions
Detailed Description
This study is a randomized controlled trial with an active control condition evaluating the impact of an art-based beauty appreciation (ABBA) intervention on trait appreciation of beauty as a primary outcome and well-being and psychological distress as secondary outcomes.
These two programs have been designed and validated in a qualitative pilot study as matched in credibility, intensity, and enjoyment.
There are three measurement points for primary and secondary outcomes, including (1) enrollment, (2) a post-test after the intervention/control program, and (3) a 4-week follow-up measure.
N = 114 participants will be randomized after baseline into either the intervention or control group (N = 57/group).
In addition, to investigate perceived mechanisms, barriers, and facilitators, participants will be selected using purposive sampling and invited to a semi-structured interview until data saturation is reached (expected N = 15).
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nijmegen, Netherlands, 6525 GA
- Radboudumc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants must be between 18-28 years of age,
- indicate that they have a smartphone to support our data collection and program components,
- have the ability and interest to make a trip to a museum or new location (i.e., new part of the city),
(3) be willing to complete short activities every day for two weeks, (4) and be fluent in English, (6) be based in Amsterdam, (7) are willing to share postal address to receive materials.
Exclusion Criteria:
- Participants must not currently be in clinical treatment for a mental health disorder, assessed via self-report, or
- indicate that they are currently experiencing severe psychological symptoms (i.e., depression, suicidal ideation, severe anxiety) via self-report.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active Control Condition
|
The active, matched control group will focus on developing pragmatic observation skills.
Participants will be instructed to pay attention to and identify objects and elements in their surroundings without emphasizing their aesthetic value.
For example, they should pay attention and count objects of the same colour they encounter, social behaviour, the people they pass on the street, or the types of buildings.
The 14-day program includes a tourist trip with guided audio instruction, watching instructional videos about increasing observation skills and completing daily written or photo journals to document their observations.
Further, participants will take an observation walk and plan to include more observation in their lives.
|
|
Other: Intervention Condition
|
The goals of the intervention program are to help individuals develop an aesthetic mindset, practice observation and appreciation skills, learn how to apply these skills to their day-to-day lives, practice emotion regulation with beauty, and incorporate more beauty into their lives.
The program is designed to create a slow skill transfer from appreciation in art contexts to natural beauty and to everyday life.
In the 14-day program, participants visit an art museum with guided audio, watch instructional videos about observing and appreciating beauty, and complete daily written or photo beauty journals that document the beauty they see.
In addition, participants will watch video art showing how to find beauty in mundane objects, practice this in a beauty walk, and complete a planning session to include more beauty in their lives.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement with Beauty
Time Frame: From baseline to the follow-up period (up to 2 months)
|
The Engagement with Beauty Scale Revised (EBS-R) is an 18-item self-report scale designed to assess cognitive and emotional engagement with natural beauty, artistic beauty, moral beauty, and beautiful ideas.
Participants respond on a 7-point Likert scale, ranging from 1 (very unlike me) to 7 (very much like me).
Example items include reflections on physiological responses to natural beauty, the spiritual experience elicited by art, and the desire for personal growth through moral beauty appreciation.
Subscales measure engagement with moral beauty (scores 6-42) and the other three domains (scores 4-28), contributing to a total score ranging from 18 to 126.
|
From baseline to the follow-up period (up to 2 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Well-being
Time Frame: From baseline to the follow-up period (up to 2 months)
|
We will measure well-being using the Mental Health Continuum Short Form (MHC-SF).
This has 14 items over three subscales: emotional well-being, social well-being (eudemonic well-being), and psychological well-being.
The items are scored on a 6-point Likert scale (0-5), then sum-scored.
|
From baseline to the follow-up period (up to 2 months)
|
|
Psychological Distress
Time Frame: From baseline to the follow-up period (up to 2 months)
|
The DASS-21 will be used to measure psychological distress.
It has 21 items divided over three subscales of 7 items each.
These capture emotional states of depression, anxiety, and stress.
The items are assessed using a four-point Likert scale (0-3), summed together, and multiplied by two.
This results in three subscales and a total score.
|
From baseline to the follow-up period (up to 2 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Regulation via Beauty
Time Frame: From baseline to the follow-up period (up to 2 months)
|
The Emotion Regulation Strategies for Artistic Creative Activities Scale (ERS-ACA; Fancourt et al., 2019) will be used with slight modification to the question stem.
While the initial purpose of this scale was geared towards creative pursuits, it has been rooted in the principles of emotion regulation theory and designed to be applied to various activities.
We anticipate that it will be a valuable instrument in evaluating how appreciating beauty can regulate emotions.
This change in the question stem concerns the use of the prompt, "When I am appreciating beauty…".
Items can be added up to avoidance strategies (i.e., I can block out unwanted thoughts or feelings), approach strategies (i.e., it makes me reflect on my emotions), and self-development strategies (i.e., it reaffirms my identity).
|
From baseline to the follow-up period (up to 2 months)
|
|
Attention Regulation
Time Frame: From baseline to the follow-up period (up to 2 months)
|
Attention regulation will be assessed using the 20-item Attention Control Scale (ACS) (Derryberry & Reed, 2002).
The questionnaire consists of 2 subscales: (1) Attention Focusing and (2) Attention Shifting.
The items are assessed on a four-point Likert scale (1-4) and will be sum-scored.
|
From baseline to the follow-up period (up to 2 months)
|
|
Mindfulness Skills
Time Frame: From baseline to the follow-up period (up to 2 months)
|
Mindfulness will be assessed using the Five Facet Mindfulness Questionnaire Short Form (FFMQ-15), with 15 items (Baer, Carmody, & Hunsinger, 2012), with five facets: (1) observing, (2) describing, (3) acting with awareness, (4) non-judging, and (5) non-reactivity (Baer et al., 2006).
The items are assessed on a five-point Likert scale (1-5) from rarely to always.
Scores will be summed for each facet and the total score.
|
From baseline to the follow-up period (up to 2 months)
|
|
Burnout
Time Frame: From baseline to the follow-up period (up to 2 months)
|
Burnout will be measured using the Burnout Assessment Tool-12 (BAT-12), consisting of 12 items (Redelinghuys & Morgan, 2023; Schaufeli et al., 2020).
This questionnaire measures burnout with four subscales: (1) Exhaustion, (2) Mental Distance, (3) Emotional Impairment, and (4) Cognitive Impairment (Schaufeli et al., 2020).
The items are assessed on a five-point Likert scale (1-5).
A total score can be obtained by calculating all items' average scores.
Additionally, subscale scores are obtained by calculating the average of the items per subscale.
|
From baseline to the follow-up period (up to 2 months)
|
|
Qualitative Interview
Time Frame: After timepoint 3 (8-9 weeks after enrollment)
|
Semi-structured interview focusing on the impacts of intervention, mechanisms, barriers and facilitators.
|
After timepoint 3 (8-9 weeks after enrollment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: MacKenzie D Trupp, PhD Candidate, RadboudUMC, Donders Institute for Brain, Cognition and Behaviour and University of Vienna
- Principal Investigator: Corina Greven, Prof. Dr., RadboudUMC, Donders Institute for Brain, Cognition and Behaviour
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 22, 2024
Primary Completion (Actual)
July 18, 2025
Study Completion (Actual)
July 18, 2025
Study Registration Dates
First Submitted
December 22, 2024
First Submitted That Met QC Criteria
January 22, 2025
First Posted (Actual)
January 23, 2025
Study Record Updates
Last Update Posted (Actual)
August 17, 2025
Last Update Submitted That Met QC Criteria
August 15, 2025
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL87597.091.24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All identifying information will remain in storage within the RadboudUMC storage systems at the Donders Institute and will not be shared.
Data will not be published; however, it will be stored in the Radboud Repository, where further researchers can request access to pseudonymized data after signing a data-access agreement.
IPD Sharing Time Frame
The study pre-registration will be embargoed on Open Science Framework (OSF) until the publication of the results in an academic journal.
IPD Sharing Access Criteria
After the release from the embargo, anyone can access the pre-registration on OSF.
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Young Adults
-
University of SharjahNot yet recruitingYoung AdultsUnited Arab Emirates
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
Riphah International UniversityRecruiting
-
Essilor InternationalNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingYoung Healthy AdultsHong Kong
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruitingHealthy Young AdultsPortugal
-
European University Miguel de CervantesCompletedHealthy Young AdultsSpain
-
Poznan University of Physical EducationCompletedHealthy Young AdultsPoland
Clinical Trials on Observation Program (Learning to Observe Life)
-
University of LethbridgeCompletedSubstance Use | Social Behavior | Emotion Regulation | Adolescent Behavior | Mindfulness | Self EsteemCanada
-
Gazi UniversityNot yet recruitingInfertility, Female | Stigma, Social
-
Hacettepe UniversityCompleted
-
Pamukkale UniversityRecruitingTelerehabilitation | Knee Arthroplasty, TotalTurkey
-
Cairo UniversityCompletedDiplegic Spastic Cerebral PalsyEgypt
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)CompletedConduct Disorder | Oppositional Defiant Disorder | Attention Deficit Disorder With HyperactivityUnited States
-
American Board of Internal MedicineThe Josiah Macy, Jr. FoundationCompleted
-
Chelsea and Westminster NHS Foundation TrustImperial College Healthcare NHS Trust; University of WestminsterCompletedMajor InjuryUnited Kingdom
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingGestational Diabetes | HydronephrosisItaly
-
Institut de Cancérologie de LorraineRecruitingNon Metastatic Breast CancerFrance